Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS

NCT02155101 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS

Interventions

DRUG: Darunavir
DRUG: ART with 2 NRTIs plus LPV/r (or ATV/r)

Sponsor

University of Liverpool

Collaborators

[object Object]
[object Object]
[object Object]